stroke
- Access DeniedThe Paradoxes of Transcatheter Aortic Valve Replacement Cardioembolic Protection DevicesSteffen Massberg and Axel BauerJACC: Cardiovascular Interventions
- Access DeniedCerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected ProceduresJulia Seeger, Jochen Wöhrle, et al.JACC: Cardiovascular Interventions
- Access DeniedRoutine Use of Embolic Protection During Transcatheter Aortic Valve ReplacementSamir R. KapadiaJACC: Cardiovascular Interventions
- Access DeniedPercutaneous Left Atrial Appendage Closure With the LAmbre Device for Stroke Prevention in Atrial FibrillationA Prospective, Multicenter Clinical StudyHe Huang, Congxin Huang, et al.JACC: Cardiovascular Interventions
- Access DeniedLeft Atrial Appendage ClosureContinuous Progress With Remaining ChallengesHorst Sievert and Stefan BertogJACC: Cardiovascular Interventions
- Access DeniedAspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable ValveThe ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical TrialJosep Rodés-Cabau, Mélanie Côté, et al.JACC: Cardiovascular Interventions
- Access DeniedThe Use of Embolic Protection Devices Is Associated With a Lower Stroke and Death Rate After Carotid StentingChristoph Knappich, Hans-Henning Eckstein, et al.JACC: Cardiovascular Interventions
- Access DeniedEmbolic Protection Devices in the SpotlightStavros Spiliopoulos and Panagiotis KitrouJACC: Cardiovascular Interventions
- Access DeniedBlurred LinesAssessing the Stent as Provocateur in Carotid InterventionWilliam A. GrayJACC: Cardiovascular Interventions
- Access DeniedThromboembolic Risk Reduction Via Transseptal Thrombus Aspiration in a Patient With Spontaneous Left Atrial Thrombus and StrokeFabian Stimpfle, Peter Seizer, et al.JACC: Cardiovascular Interventions
Pages
Advertisement